导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 54.81% | 493/4448 |
| 近一周 | -0.69% | 1576/4957 |
| 近一月 | 4.73% | 350/4942 |
| 近一季 | 3.33% | 1150/4858 |
| 近半年 | 59.81% | 266/4627 |
| 近一年 | 51.17% | 500/4420 |
| 近两年 | 56.70% | 665/3936 |
| 近三年 | 29.12% | 784/3298 |
| 成立以来 | 280.46% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
0.26% 3589/4617 |
3.31% 1785/4794 |
51.66% 350/4965 |
- - |
| 2024 | 1.71% 2309/4611 |
-2.16% 1950/4340 |
-3.89% 2753/4440 |
7.45% 3148/4543 |
0.66% 1358/4611 |
| 2023 | -17.48% 2307/4209 |
-0.08% 2369/3759 |
-2.97% 1433/3909 |
-9.22% 2365/4055 |
-6.24% 2641/4209 |
| 2022 | -24.89% 1795/3571 |
-16.12% 1065/2804 |
10.46% 895/3205 |
-15.78% 2517/3430 |
-3.74% 2342/3570 |
| 2021 | 19.37% 348/2712 |
-0.89% 494/1745 |
8.94% 1063/2232 |
6.52% 295/2560 |
3.79% 860/2708 |
| 2020 | 73.94% 234/1591 |
-2.11% 544/1036 |
24.46% 503/1256 |
22.63% 60/1472 |
16.44% 529/1690 |
| 2019 | 41.58% 377/922 |
37.87% 113/3054 |
-7.62% 2841/3201 |
7.22% 373/939 |
3.67% 870/1014 |
| 2018 | -9.65% 19/667 |
- - |
- - |
- - |
-13.23% 2534/2977 |
| 2017 | -20.67% 453/531 |
- - |
- - |
- - |
- - |
| 2016 | -19.64% 291/455 |
- - |
- - |
- - |
- - |
| 2015 | 64.70% 94/433 |
- - |
- - |
- - |
- - |
| 2014 | 13.26% 328/432 |
- - |
- - |
- - |
- - |
| 2013 | 7.03% 293/398 |
- - |
- - |
- - |
- - |
| 2012 | 19.63% 9/459 |
- - |
- - |
- - |
- - |
| 2011 | -25.72% 261/392 |
- - |
- - |
- - |
- - |
| 2010 | 6.13% 136/335 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8048 | 37.74% |
| 泰信现代服务业混合 | 2.0450 | 32.88% |
| 易方达标普生物科技人民币A | 1.7298 | 28.02% |
| 永赢高端装备智选混合发起A | 1.1625 | 27.65% |
| 永赢高端装备智选混合发起C | 1.1467 | 27.52% |
| 金信稳健策略混合A | 2.2741 | 23.08% |
| 金信精选成长混合A | 1.6584 | 22.49% |
| 金信精选成长混合C | 1.6361 | 22.31% |
| 东方人工智能主题混合C | 1.5534 | 22.12% |
| 金信行业优选混合发起式A | 2.7474 | 21.61% |
| 交银先锋混合A VS. () |